GLP-1 is a type of incretin hormone, meaning its created in the gut and released after eating a meal
Some people notice appetite changes within the first few weeks, while visible weight loss may take longer
As of August 2026, all four core Phase 3 TRIUMPH trials for retatrutide (Eli Lillys triple agonist targeting GLP-1, GIP, and glucagon receptors) have reported strong efficacy data, including up to 28.7% mean weight loss and cardiovascular benefits
3 Men in their later years of life and/or experiencing sexual impairment may benefit from this potential mechanism of L-Carnitines T-boosting activity
In the obesity group, 979 patients were studied
Het optimaliseren van deze oorzaken (zoals ongunstige leefstijlfactoren, psychosociale factoren, omzetten van medicatie met een gewichtsverhogende bijwerking), zoals ook te vinden is op www.behandelovergewicht.nl, alvorens te starten met een interventie, zal het effect van de interventie vergroten